Neural mechanisms underlying stress resilience in Ahi1 knockout mice: Relevance to neuropsychiatric disorders

Molecular Psychiatry

Volumn 19, Issue 2, 2014, Pages 243-252

  Lotan, A ^a   Lifschytz, T ^a   Slonimsky, A ^a   Broner, E C ^a   Greenbaum, L ^a   Abedat, S ^a   Fellig, Y ^a   Cohen, H ^b   Lory, O ^a   Goelman, G ^a   Lerer, B ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON HELPER INTEGRATION SITE 1 PROTEIN; CORTICOSTERONE; PROTEIN; UNCLASSIFIED DRUG; CAFFEINE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; CORE TEMPERATURE; CORTICOSTERONE RELEASE; DEPRESSION; ENDOPHENOTYPE; ENTORHINAL CORTEX; ENVIRONMENTAL STRESS; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL DISEASE; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION; SOCIAL STRESS; STRESS; VENTRAL TEGMENTUM; VISCERAL STRESS; ABELSON HELPER INTEGRATION SITE 1 GENE; ADULT; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL TISSUE; CONNECTOME; COPING BEHAVIOR; ELEVATED PLUS MAZE TEST; FUNCTIONAL NEUROIMAGING; GENE; HETEROZYGOTE; LIGHT DARK CYCLE; NEUROPATHOLOGY; OPEN FIELD TEST; REDUCTION; STARTLE REFLEX; STRESS RESILIENCE; TASK PERFORMANCE; WILD TYPE;

ANIMALS; ANXIETY; BODY TEMPERATURE; BRAIN; CORTICOSTERONE; ENVIRONMENT; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NEURONS; PITUITARY-ADRENAL SYSTEM; PROTO-ONCOGENE PROTEINS; REST; SCHIZOPHRENIA; SENSORY GATING; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 84893637150     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.123     Document Type: Article

References (86)

1. Geschwind DH. Autism: many genes, common pathways? Cell 2008; 135: 391-395.
2. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005; 10: 434-449.
3. Karlsgodt KH, Sun D, Jimenez AM, Lutkenhoff ES, Willhite R, van Erp TG et al. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 2008; 20: 1297-1327.
4. Minshew NJ, Williams DL. The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch Neurol 2007; 64: 945-950.
5. Kas MJ, Fernandes C, Schalkwyk LC, Collier DA. Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men. Mol Psychiatry 2007; 12: 324-330.
6. Mitchell KJ. The genetics of neurodevelopmental disease. Curr Opin Neurobiol 2011; 21: 197-203.
7. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 2009; 25: 528-535.
8. Dixon-Salazar T, Silhavy J, Marsh S, Louie C, Scott L, Gururaj A et al. Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am J Hum Genet 2004; 75: 979-987.
9. Ferland R, Eyaid W, Collura R, Tully L, Hill R, Al-Nouri D et al. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat Genet 2004; 36: 1008-1013.
10. Jiang X, Hanna Z, Kaouass M, Girard L, Jolicoeur P. Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J Virol 2002; 76: 9046-9059.
11. Yu F, Keinan A, Chen H, Ferland R, Hill R, Mignault A et al. Detecting natural selection by empirical comparison to random regions of the genome. Hum Mol Genet 2009; 18: 4853-4867.
12. Doering J, Kane K, Hsiao Y, Yao C, Shi B, Slowik A et al. Species differences in the expression of Ahi1, a protein implicated in the neurodevelopmental disorder Joubert syndrome, with preferential accumulation to stigmoid bodies. J Comp Neurol 2008; 511: 238-256.
13. Cheng YZ, Eley L, Hynes AM, Overman LM, Simms RJ, Barker A et al. Investigating embryonic expression patterns and evolution of AHI1 and CEP290 genes, implicated in Joubert syndrome. PLoS ONE 2012; 7: e44975.
14. Doherty D. Joubert syndrome: insights into brain development, cilium biology, and complex disease. Semin Pediatr Neurol 2009; 16: 143-154.
15. Lancaster M, Louie C, Silhavy J, Sintasath L, Decambre M, Nigam S et al. Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med 2009; 15: 1046-1054.
16. Sheng G, Xu X, Lin Y, Wang C, Rong J, Cheng D et al. Huntingtin- associated protein 1 interacts with Ahi1 to regulate cerebellar and brainstem development in mice. J Clin Invest 2008; 118: 2785-2795.
17. Lancaster MA, Gopal DJ, Kim J, Saleem SN, Silhavy JL, Louie CM et al. Defective Wnt-dependent cerebellar midline fusion in a mouse model of Joubert syndrome. Nat Med 2011; 17: 726-731.
18. Westfall JE, Hoyt C, Liu Q, Hsiao YC, Pierce EA, Page-McCaw PS et al. Retinal degeneration and failure of photoreceptor outer segment formation in mice with targeted deletion of the Joubert syndrome gene, Ahi1. J Neurosci 2010; 30: 8759-8768.
19. Louie C, Caridi G, Lopes V, Brancati F, Kispert A, Lancaster M et al. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis. Nat Genet 2010; 42: 175-180.
20. Lerer B, Segman R, Hamdan A, Kanyas K, Karni O, Kohn Y et al. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry 2003; 8: 488-498.
21. Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein R, Kohn Y, Hamdan A et al. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet 2006; 14: 1111-1119.
22. Ingason A, Sigmundsson T, Steinberg S, Sigurdsson E, Haraldsson M, Magnusdottir B et al. Support for involvement of the AHI1 locus in schizophrenia. Eur J Hum Genet 2007; 15: 988-991.
23. Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen H, Nielsen J et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 2010; 19: 1379-1386.
24. Rivero O, Reif A, Sanjua'n J, Moltó M, Kittel-Schneider S, Ná jera C et al. Impact of the AHI1 gene on the vulnerability to schizophrenia: a case-control association study. PLoS ONE 2010; 5: e12254.
25. Alvarez Retuerto A, Cantor R, Gleeson J, Ustaszewska A, Schackwitz W, Pennacchio L et al. Association of common variants in the Joubert syndrome gene (AHI1) with autism. Hum Mol Genet 2008; 17: 3887-3896.
26. Allen N, Bagade S, McQueen M, Ioannidis J, Kavvoura F, Khoury M et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008; 40: 827-834.
27. Xu X, Yang H, Lin YF, Li X, Cape A, Ressler KJ et al. Neuronal Abelson helper integration site-1 (Ahi1) deficiency in mice alters TrkB signaling with a depressive phenotype. Proc Natl Acad Sci USA 2010; 107: 19126-19131.
28. Weickert CS, Sheedy D, Rothmond DA, Dedova I, Fung S, Garrick T et al. Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry 2010; 44: 59-70.
29. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011; 474: 380-384.
30. Slonimsky A, Levy I, Kohn Y, Rigbi A, Ben-Asher E, Lancet D et al. Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder. Schizophr Res 2010; 120: 159-166.
31. Skarnes WC, von Melchner H, Wurst W, Hicks G, Nord AS, Cox T et al. A public gene trap resource for mouse functional genomics. Nat Genet 2004; 36: 543-544.
32. Cohen H, Kozlovsky N, Alona C, Matar MA, Joseph Z. Animal model for PTSD: from clinical concept to translational research. Neuropharmacology 2012; 62: 715-724.
33. Lipina TV, Palomo V, Gil C, Martinez A, Roder JC. Dual inhibitor of PDE7 and GSK-3 - VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice. Neuropharmacology 2012; 64: 205-214.
34. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004; 3: 287-302.
35. Griebel G, Belzung C, Misslin R, Vogel E. The free-exploratory paradigm: an effective method for measuring neophobic behaviour in mice and testing potential neophobia-reducing drugs. Behav Pharmacol 1993; 4: 637-644.
36. Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, Greenbaum L et al. Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement. Int J Neuropsychopharmacol 2012; 15: 1307-1318.
37. Adriaan Bouwknecht J, Olivier B, Paylor RE. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav Rev 2007; 31: 41-59.
38. Tybout A, Sternthal B, Keppel G, Verducci J, Meyers-Levy J, Barnes J et al. Analysis of variance. J Consumer Psychol 2001; 10: 5-35.
39. Paxinos G. Atlas of the Developing Mouse Brain at E17.5, P0 and P6. 1st (edn) (Elsevier: Amsterdam; Boston, 2007.
40. van den Buuse M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 2010; 36: 246-270.
41. Powell SB, Weber M, Geyer MA. Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci 2012; 12: 251-318.
42. O'Tuathaigh CM, Kirby BP, Moran PM, Waddington JL. Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull 2010; 36: 271-288.
43. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
44. Cryan JF, Sweeney FF. The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol 2011; 164: 1129-1161.
45. Zohar J, Juven-Wetzler A, Sonnino R, Cwikel-Hamzany S, Balaban E, Cohen H. New insights into secondary prevention in post-traumatic stress disorder. Dialogues Clin Neurosci 2011; 13: 301-309.
46. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 2003; 28: 1031-1044.
47. File SE. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods 1980; 2: 219-238.
48. Sanders SK, Shekhar A. Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol Psychiatry 1995; 37: 473-476.
49. Vilarim MM, Rocha Araujo DM, Nardi AE. Caffeine challenge test and panic disorder: a systematic literature review. Expert Rev Neurother 2011; 11: 1185-1195.
50. Palit G, Kumar R, Chowdhury SR, Gupta MB, Saxena RC, Srimal RC et al. A primate model of anxiety. Eur Neuropsychopharmacol 1998; 8: 195-201.
51. Kayir H, Uzbay IT. Nicotine antagonizes caffeine- but not pentylenetetrazoleinduced anxiogenic effect in mice. Psychopharmacology (Berl) 2006; 184: 464-469.
52. Lovallo WR, Al'Absi M, Blick K, Whitsett TL, Wilson MF. Stress-like adrenocorticotropin responses to caffeine in young healthy men. Pharmacol Biochem Behav 1996; 55: 365-369.
53. Hale MW, Johnson PL, Westerman AM, Abrams JK, Shekhar A, Lowry CA. Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1285-1293.
54. Lu L, Mamiya T, Koseki T, Mouri A, Nabeshima T. Genetic animal models of schizophrenia related with the hypothesis of abnormal neurodevelopment. Biol Pharm Bull 2011; 34: 1358-1363.
55. Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005; 83: 97-109.
56. Lesch KP. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 2004; 29: 174-184.
57. Malan-Muller S, Hemmings SM, Seedat S. Big effects of small RNAs: a review of microRNAs in anxiety. Mol Neurobiol 2013; 47: 726-739.
58. McIlvain V, McCasland JS. GAP-43 heterozygous mice show delayed barrel patterning, differentiation of radial glia, and downregulation of GAP-43. Anat Rec A Discov Mol Cell Evol Biol 2006; 288A: 143-157.
59. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002; 416: 396-400.
60. Lenze EJ, Wetherell JL. A lifespan view of anxiety disorders. Dialogues Clin Neurosci 2011; 13: 381-399.
61. Kas MJ, Krishnan V, Gould TD, Collier DA, Olivier B, Lesch KP et al. Advances in multidisciplinary and cross-species approaches to examine the neurobiology of psychiatric disorders. Eur Neuropsychopharmacol 2011; 21: 532-544.
62. Cryan JF, Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005; 4: 775-790.
63. Szekely M. The vagus nerve in thermoregulation and energy metabolism. Autonomic Neurosci 2000; 85: 26-38.
64. van Veen T, Goeman JJ, Monajemi R, Wardenaar KJ, Hartman CA, Snieder H et al. Different gene sets contribute to different symptom dimensions of depression and anxiety. Am J Med Genet B Neuropsychiatr Genet 2012; 159B: 519-528.
65. Luciano M, Huffman JE, Arias-Va'squez A, Vinkhuyzen AAE, Middeldorp CM, Giegling I et al. Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatric Genet 2012; 159B: 684-695.
66. Morris SE, Cuthbert BN. Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci 2012; 14: 29-37.
67. Kas MJ, Kahn RS, Collier DA, Waddington JL, Ekelund J, Porteous DJ et al. Translational neuroscience of Schizophrenia: seeking a meeting of minds between mouse and man. Sci Transl Med 2011; 3: 102mr103.
68. Bar-Haim Y, Lamy D, Pergamin L, Bakermans-Kranenburg MJ, van Ijzendoorn MH. Threat-related attentional bias in anxious and nonanxious individuals: A metaanalytic study. Psychol Bull 2007; 133: 1-24.
69. Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 2005; 8: 233-246.
70. Duncan GE, Knapp DJ, Breese GR. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res 1996; 713: 79-91.
71. Hale MW, Bouwknecht JA, Spiga F, Shekhar A, Lowry CA. Exposure to high- and low-light conditions in an open-field test of anxiety increases c-Fos expression in specific subdivisions of the rat basolateral amygdaloid complex. Brain Res Bull 2006; 71: 174-182.
72. Hale MW, Hay-Schmidt A, Mikkelsen JD, Poulsen B, Shekhar A, Lowry CA. Exposure to an open-field arena increases c-Fos expression in a distributed anxiety-related system projecting to the basolateral amygdaloid complex. Neuroscience 2008; 155: 659-672.
73. Hafting T, Fyhn M, Molden S, Moser MB, Moser EI. Microstructure of a spatial map in the entorhinal cortex. Nature 2005; 436: 801-806.
74. Witter MP, Naber PA, van Haeften T, Machielsen WCM, SARB Rombouts, Barkhof F et al. Cortico-hippocampal communication by way of parallel parahippocampalsubicular pathways. Hippocampus 2000; 10: 398-410.
75. Bertoglio LJ, Joca SRL, Guimaraes FS. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res 2006; 175: 183-188.
76. Refojo D, Holsboer F. CRH signaling. Molecular specificity for drug targeting in the CNS. Ann N Y Acad Sci 2009; 1179: 106-119.
77. Nazari-Serenjeh F, Rezayof A. Cooperative interaction between the basolateral amygdala and ventral tegmental area modulates the consolidation of inhibitory avoidance memory. Prog Neuropsychopharmacol Biol Psychiatry 2013; 40: 54-61.
78. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005; 29: 1193-1205.
79. Prediger RDS, Matheus FC, Schwarzbold ML, Lima MMS, Vital MABF. Anxiety in Parkinson's disease: a critical review of experimental and clinical studies. Neuropharmacology 2012; 62: 115-124.
80. Skelly LR, Decety J. Passive and motivated perception of emotional faces: qualitative and quantitative changes in the face processing network. PLoS ONE 2012; 7: e40371.
81. Weathington JM, Strahan JA, Cooke BM. Social experience induces sex-specific fos expression in the amygdala of the juvenile rat. Horm Behav 2012; 62: 154-161.
82. Kim MJ, Loucks RA, Palmer AL, Brown AC, Solomon KM, Marchante AN et al. The structural and functional connectivity of the amygdala: from normal emotion to pathological anxiety. Behav Brain Res 2011; 223: 403-410.
83. Markett S, Weber B, Voigt G, Montag C, Felten A, Elger C et al. Intrinsic connectivity networks and personality: the temperament dimension harm avoidance moderates functional connectivity in the resting brain. Neuroscience 2013; 240C: 98-105.
84. Franklin Tamara B, Saab Bechara J, Mansuy Isabelle M. Neural mechanisms of stress resilience and vulnerability. Neuron 2012; 75: 747-761.
85. Kofink D, Boks MP, Timmers HT, Kas MJ. Epigenetic dynamics in psychiatric disorders: environmental programming of neurodevelopmental processes. Neurosci Biobehav Rev 2013; 37: 831-845.
86. Kalkman HO. A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism 2012; 3: 10.